PAR 4.00% 26.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial, page-78

  1. 1,578 Posts.
    lightbulb Created with Sketch. 628
    Nice thought (maybe explains why no QnA to avoid a verbal slip while commercial partners on the line?). Taking it further, perhaps we have been holding off completing a deal until this data came out and we can present formally? We know that we were previously aiming for mid year for a deal (see Edison presso I think) and it’s been quiet ever since? The data is stellar and surely increases our leverage with partners!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
26.0¢
Change
0.010(4.00%)
Mkt cap ! $91.06M
Open High Low Value Volume
25.0¢ 26.0¢ 25.0¢ $36.40K 143.5K

Buyers (Bids)

No. Vol. Price($)
1 40816 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 44646 4
View Market Depth
Last trade - 16.10pm 17/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.